Methodological challenges for the valuation of drug related treatment costs for relapsing haematologic cancer patients

Henrik Vitus Bering Laursen; Charles Vesteghem; Mia Sommer; Marlene Maria Nielsen; Karen Dybkær; Tarec El-Galaly; Hans Erik Johnsen; Lars Holger Ehlers; Martin Bøgsted

doi:10.1111/bcpt.13020

Methodological challenges for the valuation of drug related treatment costs for relapsing haematologic cancer patients

Henrik Vitus Bering Laursen
, Charles Vesteghem
, Mia Sommer
, Marlene Maria Nielsen
, Karen Dybkær
, Tarec El-Galaly
, Hans Erik Johnsen
, Lars Holger Ehlers
, Martin Bøgsted

Research output: Contribution to journal › Conference abstract in journal › Research

292 Downloads (Pure)

Original language	English
Article number	NorPM-P22
Journal	Basic & Clinical Pharmacology & Toxicology
Volume	123
Issue number	Suppl. 1
Pages (from-to)	9
ISSN	1742-7843
DOIs	https://doi.org/10.1111/bcpt.13020
Publication status	Published - May 2018
Event	First Nordic conference on Personalized Medicine - Nyborg, Denmark Duration: 30 May 2018 → 1 Jun 2018 Conference number: 1 http://www.norpm2018.com/

Conference

Conference	First Nordic conference on Personalized Medicine
Number	1
Country/Territory	Denmark
City	Nyborg
Period	30/05/2018 → 01/06/2018
Internet address	http://www.norpm2018.com/

Access to Document

10.1111/bcpt.13020

NorPM-148-preview-2

AUB Link

Search for the material in Aalborg University Library's search engine

1 Poster

Methodological challenges for the valuation of drug related treatment costs for relapsing haematological cancer patients
Laursen, H. V. B., Vesteghem, C., Sommer, M., Nielsen, M. M., Dybkær, K., El-Galaly, T., Johnsen, H. E., Ehlers, L. H. & Bøgsted, M., 28 May 2018.
Research output: Contribution to conference without publisher/journal › Poster › Research

Cite this

Laursen, H. V. B., Vesteghem, C., Sommer, M., Nielsen, M. M., Dybkær, K., El-Galaly, T., Johnsen, H. E., Ehlers, L. H., & Bøgsted, M. (2018). Methodological challenges for the valuation of drug related treatment costs for relapsing haematologic cancer patients. Basic & Clinical Pharmacology & Toxicology, 123(Suppl. 1), 9. Article NorPM-P22. https://doi.org/10.1111/bcpt.13020

@article{9bf3ccd1f9f14043b9699b0a289a8a3a,

title = "Methodological challenges for the valuation of drug related treatment costs for relapsing haematologic cancer patients",

author = "Laursen, \{Henrik Vitus Bering\} and Charles Vesteghem and Mia Sommer and Nielsen, \{Marlene Maria\} and Karen Dybk{\ae}r and Tarec El-Galaly and Johnsen, \{Hans Erik\} and Ehlers, \{Lars Holger\} and Martin B{\o}gsted",

year = "2018",

month = may,

doi = "10.1111/bcpt.13020",

language = "English",

volume = "123",

pages = "9",

journal = "Basic \& Clinical Pharmacology \& Toxicology",

issn = "1742-7843",

publisher = "Wiley-Blackwell",

number = "Suppl. 1",

note = "First Nordic conference on Personalized Medicine ; Conference date: 30-05-2018 Through 01-06-2018",

url = "http://www.norpm2018.com/",

}

Methodological challenges for the valuation of drug related treatment costs for relapsing haematologic cancer patients. / Laursen, Henrik Vitus Bering; Vesteghem, Charles; Sommer, Mia et al.
In: Basic & Clinical Pharmacology & Toxicology, Vol. 123, No. Suppl. 1, NorPM-P22, 05.2018, p. 9.

Research output: Contribution to journal › Conference abstract in journal › Research

TY - ABST

T1 - Methodological challenges for the valuation of drug related treatment costs for relapsing haematologic cancer patients

AU - Laursen, Henrik Vitus Bering

AU - Vesteghem, Charles

AU - Sommer, Mia

AU - Nielsen, Marlene Maria

AU - Dybkær, Karen

AU - El-Galaly, Tarec

AU - Johnsen, Hans Erik

AU - Ehlers, Lars Holger

AU - Bøgsted, Martin

N1 - Conference code: 1

PY - 2018/5

Y1 - 2018/5

U2 - 10.1111/bcpt.13020

DO - 10.1111/bcpt.13020

M3 - Conference abstract in journal

SN - 1742-7843

VL - 123

SP - 9

JO - Basic & Clinical Pharmacology & Toxicology

JF - Basic & Clinical Pharmacology & Toxicology

IS - Suppl. 1

M1 - NorPM-P22

T2 - First Nordic conference on Personalized Medicine

Y2 - 30 May 2018 through 1 June 2018

ER -

Methodological challenges for the valuation of drug related treatment costs for relapsing haematologic cancer patients

Conference

Access to Document

AUB Link

Research output

Methodological challenges for the valuation of drug related treatment costs for relapsing haematological cancer patients

Cite this